| Name | Title | Contact Details |
|---|
Specializing in post-acquisition integration and restructuring, achieving operational excellence, supporting buyers like private equity firms with due diligence and deal dynamics, as well as coaching and development.
We are a community bank focused on doing whats best for our customers -- whether its providing a new service that works for more people, or taking the time to ask what more we can do to help. We offer every convenience for banking off-site or on-line, but never, ever compromise on personal attention. And proud as we are of our history dating back to 1868, our sights are firmly -- and optimistically -- set on whats ahead. Gorham Savings Bank is dedicated to improving the economic and social well-being of our customers and the communities we serve and committed to be the leading financial service provider in creating economic growth, prosperity, and financial security for the citizens and communities of Southern Maine by: • Developing and delivering quality products and services to our customers. • Establishing a workplace environment that attracts and retains highly motivated, high performing employees. • Achieving sound financial results which will allow us to reinvest in our company and in our communities in a meaningful and sustainable manner. Member FDIC - Equal Housing Lender
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
The founder of Conval, Chester A. Siver, developed an innovative and technologically advanced line of forged steel globe valves for high pressure and high temperature steam service applications primarily for the power generation industry. In 1967, Conval was incorporated and manufacturing facilities were established in Somers, Connecticut. Conval has developed extensions to the original product line which include: • "T" and angle pattern bodies • 3500 pound and a 4500 pound series • 2 1/2, 3, and 4 inch sizes • Bellows seal valves • 3 way valves • A variety of material options • Cryogenic valves • Multiple orifice blowdown valves • Ball Valves • Nuclear Power Plant Valves Convals provides basic valve products that are durable, maintainable, and yield a low cost solution over the serviceable life of the valve. Markets for Conval include the power generation industry, refining, oil and gas production, chemical, fertilizer, and pulp industries. Besides the domestic United States market, other projected growth markets are Canada, Australia, China, Southeast Asia, Mexico, South America, and developing third world countries. Over one half of Convals sales are made internationally. Conval became a Certified ISO 9001 manufacturer in September 1992. BVQI (Bureau Veritas Quality International, N.A., Inc.) semi-annually certifies that Convals Quality Management System is in accordance with appropriate international standards for design, development, production, installation, and servicing. Also, Convals quality program meets the requirements of 10CFR50, Appendix B of the Code of Federal Regulations and ASME N Stamp for its nuclear customers, and the European Pressure Equipment Directive. Conval employs approximately 100 employees working on two shifts. Convals operations consist of the machining of most parts used to assemble finished valves, the maintenance of adequate parts inventory to support production, and the development of new valve products.
Arch Insurance Group Inc., a division of Arch Capital Group Ltd. (ACGL), is a market-leading specialty insurer. We provide a wide range of property, casualty and specialty insurance for corporations, professional firms and financial institutions across the United States and Canada. Our insurance group in North America consists of Arch Insurance Company, Arch Specialty Insurance Company and Arch Excess & Surplus Insurance Company. Arch Insurance Groups executive offices are located at One Liberty Plaza in New York City, with regional offices located in New York City (Northeast Region), Atlanta (Southeast Region), Chicago (Central Region) and San Francisco (Western Region), as well as other offices throughout the U.S. to support our business. Arch Insurance Company also operates a branch office in Toronto, Canada. ACGL is a Bermuda public limited liability company that provides insurance, reinsurance and mortgage insurance on a worldwide basis through operations in Bermuda, the United States, Canada, Europe, Australia and Hong Kong.